Final outcome paper of the SENTIX study published in Nature Cancer!

We are pleased to share the latest publication from the ENGOT-Cx2/CEEGOG CX-01/SENTIX academic surgical trial, now published in Nature Cancer.

This prospective, single-arm, international trial evaluated the safety of sentinel lymph node biopsy without systematic pelvic lymphadenectomy in patients with early-stage cervical cancer. The final survival outcomes provide valuable evidence to inform both clinical practice and future research.

Notably, half of the patients enrolled in the SENTIX study came from CEEGOG sites. We sincerely thank all participating sites and collaborators for their invaluable contribution.

📄 Read the full article here: https://www.nature.com/articles/s43018-025-01016-y#citeas